OS Therapies files prospectus supplement for share resale
OS Therapies filed a prospectus supplement covering the resale of up to 5,874,094 common shares and included counsel’s legal opinion on the shares’ legality.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.